The Board of a young wound care company asked our medical device consultants to identify target companies and project manage their exit through a trade sale.
A young wound care company with a novel product in clinical trials was seeking an exit post CE marking. Our medical device consultants were asked by the Board to undertake the business development phase of the exit planning by engaging with potential target companies and canvassing their interest in an acquisition or licensing deal. We developed an exit plan including presentational material and a review of recent deals in this space, and then used our specialist sector knowledge to identify likely target companies and individuals in those companies to contact. We then managed the relationship with interested companies by answering questions and providing update on clinical trials, and providing feedback to the Board.
We also provided regular reports to the Board on competitor developments that might impact on an exit and company valuation, and the competitiveness of the novel wound care product.
We are a specialist medical device consultancy consisting of industry experts with long and successful track records in commercialising medical device products. We have broad functional and sector experience, and would welcome an opportunity to discuss with you any challenge relating to creating sustainable value from medical technologies.
Munna Choudhury of Alacramed will be attending UK BIOTECH SUMMIT 2019, on
Mark Wickham of Alacramed will be attending Med-Tech Innovation Expo 2019 at
We understand the need for accurate, tailored health economic and budget impact
Alacramed Ltd, St Johns Innovation Centre, Cowley Road, Cambridge,
+44 (0) 1223 421885